819
Views
25
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Antibiotic Resistance in Sputum Isolates of Streptococcus pneumoniae in Chronic Obstructive Pulmonary Disease is Related to Antibiotic Exposure

, , , , , , , & show all
Pages 337-344 | Published online: 20 Sep 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Daniel Smith, Arran Gill, Lewis Hall & Alice M. Turner. (2021) Prevalence, Pattern, Risks Factors and Consequences of Antibiotic Resistance in COPD: A Systematic Review. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:6, pages 672-682.
Read now
Victoria Beasley, Priya V Joshi, Aran Singanayagam, Philip L Molyneaux, Sebastian L Johnston & Patrick Mallia. (2012) Lung microbiology and exacerbations in COPD. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 555-569.
Read now

Articles from other publishers (23)

Salma Messous, Imen Trabelsi, Khaoula Bel Haj Ali, Ahmed Abdelghani, Yosra Ben Daya, Rabie Razgallah, Mohamed Habib Grissa, Kaouthar Beltaief, Zied Mezgar, Asma Belguith, Wahid Bouida, Riadh Boukef, Hamdi Boubaker, Mohamed Amine Msolli, Adel Sekma & Semir Nouira. (2022) Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial . Therapeutic Advances in Respiratory Disease 16, pages 175346662210997.
Crossref
Msolli Mohamed Amine, Messous Selma, Sekma Adel, Bel haj ali Khaoula, Khalil Mohamed Hassene, Trabelsi Imen, Abdelghani Ahmed, Ben Brahim Nadia, Ben Dhaya Yosra, Razgallah Rabie, Grissa Mohamed Habib, Beltaief Kaouthar, Methamem Mehdi, Belguith Asma, Bouida Wahid, Boukef Riadh, Boubaker Hamdi & Nouira Semir. (2021) 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial. PLOS ONE 16:5, pages e0251716.
Crossref
Monique R. Bidell, Manjunath (Amit) P. Pai & Thomas P. Lodise. (2020) Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class. Antibiotics 9:12, pages 905.
Crossref
Rajesh Kunadharaju & Sanjay Sethi. (2020) Treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 41:3, pages 439-451.
Crossref
Nick A Francis, David Gillespie, Patrick White, Janine Bates, Rachel Lowe, Bernadette Sewell, Rhiannon Phillips, Helen Stanton, Nigel Kirby, Mandy Wootton, Emma Thomas-Jones, Kerenza Hood, Carl Llor, Jochen Cals, Hasse Melbye, Gurudutt Naik, Micaela Gal, Deborah Fitzsimmons, Mohammed Fasihul Alam, Evgenia Riga, Ann Cochrane & Christopher C Butler. (2020) C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT. Health Technology Assessment 24:15, pages 1-108.
Crossref
Xing An, Chuantao Zhang, Xiangwen Weng, Wei Xiao, Zengtao Sun, Zhu Zeng & Qingsong Huang. (2020) C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. Medicine 99:29, pages e21152.
Crossref
Kristina Vermeersch, Maria Gabrovska, Joseph Aumann, Ingel K. Demedts, Jean-Louis Corhay, Eric Marchand, Hans Slabbynck, Christel Haenebalcke, Michiel Haerens, Shane Hanon, Paul Jordens, Rudi Peché, Antoine Fremault, Tine Lauwerier, Anja Delporte, Bert Vandenberk, Rik Willems, Stephanie Everaerts, Ann Belmans, Kris Bogaerts, Geert M. Verleden, Thierry Troosters, Vincent Ninane, Guy G. Brusselle & Wim Janssens. (2019) Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine 200:7, pages 857-868.
Crossref
Brianna Atto, Mathew Suji Eapen, Pawan Sharma, Urs Frey, Alaina J. Ammit, James Markos, Collin Chia, Josie Larby, Greg Haug, Heinrich C. Weber, George Mabeza, Stephen Tristram, Stephen Myers, Dominic P. Geraghty, Katie L. Flanagan, Philip M. Hansbro & Sukhwinder Singh Sohal. (2019) New therapeutic targets for the prevention of infectious acute exacerbations of COPD: role of epithelial adhesion molecules and inflammatory pathways. Clinical Science 133:14, pages 1663-1703.
Crossref
Christopher C. Butler, David GillespiePatrick WhiteJanine BatesRachel LoweEmma Thomas-JonesMandy WoottonKerenza HoodRhiannon PhillipsHasse MelbyeCarl LlorJochen W.L. CalsGurudutt NaikNigel KirbyMicaela GalEvgenia RigaNick A. Francis. (2019) C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. New England Journal of Medicine 381:2, pages 111-120.
Crossref
H.J. Prins, Ruud Duijkers, Paul van der Valk, Marianne Schoorl, Johannes M.A. Daniels, Tjip S. van der Werf & Wim G. Boersma. (2019) CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions. European Respiratory Journal 53:5, pages 1802014.
Crossref
David M. Jacobs, Ursula Pandit & Sanjay Sethi. (2019) Acute exacerbations in chronic obstructive pulmonary disease. Current Opinion in Infectious Diseases 32:2, pages 143-151.
Crossref
Brian T. Tsuji, James Fisher, Raheal Boadi-Yeboah, Patricia N. Holden, Sanjay Sethi, Melinda M. Pettigrew & Timothy F. Murphy. (2018) Azithromycin Pharmacodynamics against Persistent Haemophilus influenzae in Chronic Obstructive Pulmonary Disease. Antimicrobial Agents and Chemotherapy 62:2.
Crossref
Janine Bates, Nick A. Francis, Patrick White, David Gillespie, Emma Thomas-Jones, Rachel Breen, Nigel Kirby, Kerry Hood, Micaela Gal, Rhiannon Phillips, Gurudutt Naik, Jochen Cals, Carl Llor, Hasse Melbye, Mandy Wootton, Evgenia Riga, Ann Cochrane, Robin Howe, Deborah Fitzsimmons, Bernadette Sewell, Mohammed Fasihul Alam & Christopher C. Butler. (2017) General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial. Trials 18:1.
Crossref
Luke V. Blakeway, Aimee Tan, Ian R. A. Peak & Kate L. Seib. (2017) Virulence determinants of Moraxella catarrhalis: distribution and considerations for vaccine development. Microbiology 163:10, pages 1371-1384.
Crossref
Janice M. Leung, Pei Yee Tiew, Micheál Mac Aogáin, Kurtis F. Budden, Valerie Fei Lee Yong, Sangeeta S. Thomas, Kevin Pethe, Philip M. Hansbro & Sanjay H. Chotirmall. (2017) The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD. Respirology 22:4, pages 634-650.
Crossref
Colleen McGoldrick, Thomas Ulahannan & Katrina Lane Krebs. (2016) Review of antibiotic use in respiratory disorders at a regional hospital in Queensland. Collegian 23:4, pages 391-395.
Crossref
Leopoldo N. Segal, Michael D. Weiden & Harold W. Horowitz. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 810 817.e3 .
M. Fanning, M. McKean, K. Seymour, P. Pillans & I. Scott. (2014) Adherence to guideline-based antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease in an Australian tertiary hospital. Internal Medicine Journal 44:9, pages 903-910.
Crossref
Himanshu Desai, Karen Eschberger, Catherine Wrona, Lori Grove, Aarti Agrawal, Brydon Grant, Jingjing Yin, G. Iyer Parameswaran, Timothy Murphy & Sanjay Sethi. (2014) Bacterial Colonization Increases Daily Symptoms in Patients with Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society 11:3, pages 303-309.
Crossref
Kamen Rangelov & Sanjay Sethi. (2014) Role of Infections. Clinics in Chest Medicine 35:1, pages 87-100.
Crossref
David J Serisier. (2013) Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases. The Lancet Respiratory Medicine 1:3, pages 262-274.
Crossref
David R. Meek, Martin D. Knolle & Thomas B. Pulimood. 2013. Essentials of Palliative Care. Essentials of Palliative Care 395 415 .
Richard P. Wenzel, Alpha A. FowlerIIIIII & Michael B. Edmond. (2012) Antibiotic Prevention of Acute Exacerbations of COPD. New England Journal of Medicine 367:4, pages 340-347.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.